A child with crescentic glomerulonephritis following SARS-CoV-2 mRNA (Pfizer-BioNTech) vaccination
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hanna C, Herrera Hernandez LP, Bu L, Kizilbash S, Najera L, Rheault MN, Czyzyk J, Kouri AM (2021) IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine. Kidney Int 100:705–706. https://doi.org/10.1016/j.kint.2021.06.032
Sekar A, Campbell R, Tabbara J, Rastogi P (2021) ANCA glomerulonephritis after the Moderna COVID-19 vaccination. Kidney Int 100:473–474. https://doi.org/10.1016/j.kint.2021.05.017
Anderegg MA, Liu M, Saganas C, Montani M, Vogt B, Huynh-Do U, Fuster DG (2021) De novo vasculitis after mRNA-1273 (Moderna) vaccination. Kidney Int 100:474–476. https://doi.org/10.1016/j.kint.2021.05.016
Feghali EJ, Zafar M, Abid S, Santoriello D, Mehta S (2021) De-novo antineutrophil cytoplasmic antibody-associated vasculitis following the mRNA-1273 (Moderna) vaccine for COVID-19. Cureus 13:e19616. https://doi.org/10.7759/cureus.19616
Hakroush S, Tampe B (2021) Case report: ANCA-associated vasculitis presenting with rhabdomyolysis and pauci-immune crescentic glomerulonephritis after Pfizer-BioNTech COVID-19 mRNA vaccination. Front Immunol 12:762006. https://doi.org/10.3389/fimmu.2021.762006
Sacker A, Kung V, Andeen N (2021) Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination. Kidney Int 100:471–472. https://doi.org/10.1016/j.kint.2021.06.006
Shakoor MT, Birkenbach MP, Lynch M (2021) ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis 78:611–613. https://doi.org/10.1053/j.ajkd.2021.06.016
Tan HZ, Tan RY, Choo JCJ, Lim CC, Tan CS, Loh AHL, Tien CS, Tan PH, Woo KT (2021) Is COVID-19 vaccination unmasking glomerulonephritis? Kidney Int 100:469–471. https://doi.org/10.1016/j.kint.2021.05.009
Li NL, Coates PT, Rovin BH (2021) COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation? Kidney Int 100:959–965. https://doi.org/10.1016/j.kint.2021.09.002